Stratophase Announces a Joint Collaboration With Merck

Romsey, United Kingdom --- Stratophase, a biotech services and technology company, has entered into a joint collaboration agreement with Merck science and technology company. The collaboration will see the application of Stratophase’s Ranger technology to Merck’s cell culture manufacturing platforms and the development of dynamic control strategies that enable complex feeding regimes to be optimised and controlled in real-time. Enhancement of the existing Ranger system’s capabilities to enable control of cell culture processes with complex feeding requirements is aligned with the biopharmaceutical industry’s increasing need for high performance and robust processes that can be optimised and implemented within minimum timelines.

Suggested Articles

Fieldscale’s SENSE development platform will lower design time and costs, companies claim

Avnet posted GAAP earnings per share from continuing operations of 5 cents per share on sales of $4.5 billion, down from a year ago.

Data Center group reached 4Q record at Intel, at $7.2 billion